University of Sao Paulo

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

233

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

2 drugs in development

Approved1

Phase 21

Phase 11

By Therapeutic Area

top 2

Psychiatry

267%

Oncology

133%

R&D Momentum

61/100

Pipeline Velocity

32/100

Trial Completion Rate

90/100

Pipeline Concentration

56/100

Pipeline Freshness

7/100

Strategic Signals

↗Active in Psychiatry but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Jul 11, 2026

Suspended

Graviceptive Neglect After Stroke: Clinical, Neuroanatomical and Physiological Effects of Focal Neuromodulation

Jul 1, 2026

Recruiting

Esketamine Versus Crisis Response Planning Versus Optimized Treatment as Usual for Suicide Prevention: A Pragmatic Controlled Trial in Two Brazilian Cities

Earlier

Jun 25, 2026TrialEfficacy of a Face-to-face Versus a Remote Physiotherapy Instruction Session About Pelvic Floor in the Pelvic Floor Muscle Capacity of Incontinent Women: a Randomized Controlled Trial

Jun 24, 2026TrialTranscranial Alternating Current Stimulation for the Treatment of Anxiety and Insomnia: An Open-Label Pilot Clinical Trial

Jun 24, 2026TrialCD19-targeted Lymphocyte Engineering Validation for the trEatment of Refractory Systemic Lupus Erythematosus

Jun 23, 2026TrialPhysiotherapeutic Approach to Superficial and Deep Dyspareunia in Women With Chronic Pelvic Pain: Comparison Between In-person and Telehealth Care.

Mar 9, 2026TrialEmpagliflozin Adjunctive Therapy in Bipolar Depression

Jan 9, 2026TrialEvaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

2 more events

Dec 20, 2025TrialAyahuasca, Esketamine and Premenstrual Symptoms

Dec 20, 2025TrialAyahuasca, Esketamine and Body Image Perception

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)